share_log

11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

11-K：员工持股年度报告
美股SEC公告 ·  06/25 16:26
Moomoo AI 已提取核心信息
Bristol-Myers Squibb Company (BMY.US), a leading pharmaceutical company, has filed its annual Form 11-K with the Securities and Exchange Commission for the fiscal year ended December 31, 2023. The report details the financial performance of the Bristol-Myers Squibb Company Employee Incentive Thrift Plan, which is a defined contribution retirement plan for its employees. The plan includes a variety of investment options and is subject to ERISA provisions. The financial statements, audited by Withum Smith + Brown, PC, indicate that the plan's net assets available for benefits decreased from $62,527,000 at the beginning of the year to $60,622,000 at the end of the year. The decrease is attributed to distributions and withdrawals exceeding total additions from net investment income and contributions. The...Show More
Bristol-Myers Squibb Company (BMY.US), a leading pharmaceutical company, has filed its annual Form 11-K with the Securities and Exchange Commission for the fiscal year ended December 31, 2023. The report details the financial performance of the Bristol-Myers Squibb Company Employee Incentive Thrift Plan, which is a defined contribution retirement plan for its employees. The plan includes a variety of investment options and is subject to ERISA provisions. The financial statements, audited by Withum Smith + Brown, PC, indicate that the plan's net assets available for benefits decreased from $62,527,000 at the beginning of the year to $60,622,000 at the end of the year. The decrease is attributed to distributions and withdrawals exceeding total additions from net investment income and contributions. The plan's investments are held in the Savings Plan Master Trust, which includes mutual funds, company stock, money market funds, and other assets. The report, signed by Senior Vice President and Treasurer Sandra Ramos-Alves on June 25, 2024, confirms the plan's compliance with U.S. GAAP and its tax-exempt status under the Code.
领先的药品公司施贵宝公司（BMY.US）已向证券交易委员会提交了截至2023年12月31日的财政年度的年度11-K表格。该报告详细说明了施贵宝公司员工激励储蓄计划的财务状况，该计划是为其雇员而设的一项确定性贡献养老计划。该计划包括各种投资选择，并受ERISA条款的约束。由Withum Smith + Brown，PC审计的基本财务报表显示，计划的净可用资产从年初的6252.7万美元减少至年底的6062.2万美元。这一下降归因于分配和提款超过了净投资收益和捐款的总额。该计划的投资持有在储蓄计划主信托中，其中包括共同基金、公司股票、货币市场基金和其他资产。报告由高级副总裁兼财务总监桑德拉·拉莫斯-阿尔韦斯于2024年6月25日签署，确认该计划符合美国公认会计原则和税收减免编码的规定。
领先的药品公司施贵宝公司（BMY.US）已向证券交易委员会提交了截至2023年12月31日的财政年度的年度11-K表格。该报告详细说明了施贵宝公司员工激励储蓄计划的财务状况，该计划是为其雇员而设的一项确定性贡献养老计划。该计划包括各种投资选择，并受ERISA条款的约束。由Withum Smith + Brown，PC审计的基本财务报表显示，计划的净可用资产从年初的6252.7万美元减少至年底的6062.2万美元。这一下降归因于分配和提款超过了净投资收益和捐款的总额。该计划的投资持有在储蓄计划主信托中，其中包括共同基金、公司股票、货币市场基金和其他资产。报告由高级副总裁兼财务总监桑德拉·拉莫斯-阿尔韦斯于2024年6月25日签署，确认该计划符合美国公认会计原则和税收减免编码的规定。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息